electroCore, Inc.

NASDAQ:ECOR

Medical - Devices

Healthcare
$7.71 -5.70%

-$0.50 today

Market cap
$71.13M
Beta
0.87
P/E (TTM)
-4.8
EPS (TTM)
-$1.72
52W Low $4.16High $10.50

Volume 0.06M

Average 0.11M

ECOR Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

electroCore, Inc.NASDAQ: ECOR

Cost of Revenue · Q1 FY2026 · quarter ended Mar 2026

Cost of revenue growth accelerates

Q1 FY2026 cost of revenue of $1.22M rose 20.4% year over year, ahead of the +13.8% change in trailing-twelve-month cost of revenue. Sequentially, it rose 13.7% from the prior quarter. Over 3 fiscal years it compounded at +38.0% a year.

Context

  • Cost of revenue amounted to 13.2% of revenue in FY2025, down 1.8 pp from a year earlier.
  • Cost of revenue increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +20.4% holds above the trailing-twelve-month pace of +13.8%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$1.22M+13.7% QoQ
Last fiscal yearDec 2025
$4.24M+12.1% YoY
LTMMar 2026
$4.45M+13.8% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+20.4%——
1 year+12.1%——
3-year CAGR+38.0%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2025
4.24M USD
Year-over-year change
+12.1%
4-year CAGR
+32.3%

Cost of Revenue vs competitors

How ECOR compares with its peers on the latest reported figures

  • ECOR's LTM Mar 2026 cost of revenue of $4.45M is the 2nd highest of the 6 companies compared; the peer median is $303.24K.
  • Its year-over-year change of +13.8% is the 3rd highest of 4, against a peer median of +26.0%.
  • Cost of revenue amounts to 12.8% of revenue for ECOR, versus a peer median of 21.6%.
ECOR Competitors Peer median
Cost of Revenue for ECOR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MYOMyomo, Inc.LTM Mar 2026$14.03M +26.0%+38.3%34.0%
ECORelectroCore, Inc.LTM Mar 2026$4.45M +13.8%+38.0%12.8%
RNXTRenovoRx, Inc.LTM Mar 2026$317K +237.2%—21.3%
HYPDHyperion DeFi, Inc.LTM Jun 2026$303.24K -90.8%—21.6%
PYPDPolyPid Ltd.LTM Mar 2026$0 ———
MAIAMAIA Biotechnology, Inc.LTM Mar 2026$0 ———
Peer median (excluding ECOR) $303.24K+26.0%+38.3%21.6%

Competitors are the stored peer set for ECOR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue5.45M8.59M16.03M25.18M32.03M
Cost of Revenue1.39M1.62M2.8M3.79M4.24M
Gross Profit4.07M6.98M13.23M21.4M27.79M
Gross Margin74.6%81.2%82.5%85.0%86.8%
Research & Development2.54M5.52M5.32M2.36M2.74M
Selling, General & Admin21.57M24.33M26.71M31.2M38.21M
Operating Expenses24.11M29.85M32.03M33.56M40.94M
Depreciation & Amortization382K596K1.26M1.26M1.68M
EBITDA(17.69M)(22M)(17.76M)(10.72M)(11.7M)
EBITDA Margin-324.5%-256.0%-110.8%-42.6%-36.5%
Operating Income(20.04M)(22.87M)(18.81M)(12.16M)(13.15M)
Operating Margin-367.7%-266.2%-117.3%-48.3%-41.1%
Interest Income11K287K433K572K298K
Interest Expense0000590K
Other Income / Expenses1.97M281K(215K)183K(810K)
Income Before Tax(18.07M)(22.59M)(19.02M)(11.98M)(13.96M)
Pre-Tax Margin-331.5%-263.0%-118.7%-47.6%-43.6%
Income Tax Expense(851K)(431K)(186K)(93K)3K
Net Income(17.22M)(22.16M)(18.83M)(11.89M)(13.97M)
Net Margin-315.9%-257.9%-117.5%-47.2%-43.6%
EPS (Basic)(4.36)(4.69)(3.42)(1.59)(1.65)
EPS (Diluted)(4.36)(4.69)(3.42)(1.59)(1.65)
Weighted Avg Shares3.95M4.73M5.52M7.48M8.48M
Weighted Avg Shares (Diluted)3.95M4.73M5.52M7.48M8.48M

electroCore, Inc.

NASDAQ:ECOR

Intrinsic Alpha fair value

Locked

Current Price

$7.71

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.